Antibe Therapeutics Inc(Pre-Merger) ATBPF

New Hires ...

[MrMugsy]

As expected ... we now have two new board members with experience in capital markets and partnering.

Forward we go !!!!

[Forestview]

Great news indeed.  I didn't see anyting about stocks granted to these two.  What's typically the process to get these folks to have some skin in the game?  Anyone shed some light on this?  Mugs?

[MasterAlgae]

Well that's the first press release I predicted now I'd expect another one with more 'umph' before the roll-back. Question is - do they issue the press release announcing the filing of their NASDAQ listing application before the roll-back or after?

[MrMugsy]

I'm going to guess ... Reverse Split - first week of December. Detailed Shareholder Update - to follow. Uplisting in the New Year - maybe some insight in the Shareholder Update to guide us. IMO

[Doccole]

Hey all, if board directors and hiring of rain maker is the press releases, we are in trouble.  Regardless of the float, that's not substantial news.  I would fear or be at least concerned of financing to acquire enough money for phase 3(which we don't have).  Thoughts?

[MrMugsy]

The way I look at it is ... ATE has to assume they are going to be a standalone company going into P3 and they have to go into negotiations with Big Pharma with a backup plan of going-it-alone.  Everything they are doing is senting Big Pharma a message that "ATE doesn't need them, they'd like them, but we don't necessarily need them." We knew they were making a hire

[JohnnySins]

We will certainly need more $$, approximately $30M-$40M if my calculations are correct. But this is nothing new... probably fund raise Q1 and Q2 if needed.

[MrMugsy]

Exactly ... we have allocated the funds ($5M) for the dosing part of P3. We are good to start. We still have lots of negotiating work to get to our goal of partnering for Phase 3. There are still a lot of R&D developments and FDA administrative work to follow (and hopefully good news from that) ... before we get to Phase 3. Excitement should build as we attempt to partner. Anything can

[bringon10bagger]

Unmet Medical Need: Millions of Americans Could Benefit from Next-Generation NSAIDs | 2020-11-24 | Press Releases | Stockhouse

[bringon10bagger]

Very interesting to compare other Naz listed biotech/pharma company all in early phase developments, all 3 have market caps between 1.6-2.2 billion and Antibe heading to phase III, with a MC of 150M, now that's a gross disparity.........we'll take a 1.6B mc for $4/share...........positioning to expect at some point.

[AntibeTribe]

I'm curious as to which companies you're looking at there, 10bag?

[baggerx99]

I believe it must be this Nonsteroidal anti-inflammatory drugs, or NSAIDs are among the most widely used medications in the world for pain and inflammation. In fact, more than 33 million Americans use them regularly, and more than 30 billion doses of NSAIDs are administered annually in the U.S., according to MedicineNet. Unfortunately, some 25% of people taking these medicines develop

[bringon10bagger]

here's the link.........

[Doccole]

At 38m shares with a eval at 1.6b the share price would be 42, no? if we had 380m at 1.6b our share price would be 4ish, correct?  my math right?

[MrMugsy]

Ya - sounds right. I have a standing bet with a friend that ATE is bought out before we go to P3 at a value of 2 billion. That's about $4.44 per share value (in my head anyway). The only reason I said $4.44 ... the last tech company I owned was purchased for $4.44. I thought it only fitting that this one would be purchased for the exact same price per share. hahaha ! Good Luck to all

[Doccole]

Alright Mugs, I want some of that action.  I'll take the over 2b.

[AntibeTribe]

Please, Mugs, tell me, is this $4.44 before or after RS?

[MrMugsy]

Hahaha ! Yes ... before the reverse split. ---------- Along the same line ... I really hope I'm aiming too low with that guess.  I can't wait to see what the academic studies show ... and I think it relates to Dan's recent comment ... “We’re going to initiate a whole new field around what are called the gaseous mediators: nitric oxide, hydrogen sulfide, and carbon monoxide

[endpntplay]

I think Q1 they have an equity sale to a big pharma partner to fund the trial. 

[Forestview]

I suspect Doc that there is a strategy to releasing these announcements, and that this isn't the last of it.  

[Doccole]

Let's hope! I hope someone is guiding this process with knowledge and experience! Glta 

[Pragmatist]

Doc, I look upon the hiring of the rainmaker/dealmaker as a harbinger of good things to come.  You might recall from the LD 500 presention in September, that the plan was for this individual to pursue the large marketing partners.  So some news about his hiring could be very meaningul, and  perhaps, more so than the recent announcements.  Just my view.

[Doccole]

Very true! anyway this company could be acquired for 7-10b? i can't wait to be out of penny stock hell!